Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

OSR Holdings, Inc. OSRH NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

OSR Holdings, Inc. (OSRH) is a Biotechnology company in the Healthcare sector, currently trading at $0.55. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Valuation: OSRH trades at a trailing Price-to-Earnings (P/E) of -0.1 (S&P 500 average ~25).

Financials: revenue is $3M, +0%/yr average growth. Net income is $29M (loss), growing at -619.1%/yr. Net profit margin is -994.2% (negative). Gross margin is 20.4% (+0 pp trend).

Balance sheet: total debt is $0 against $78M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 0.1 (tight liquidity). Debt-to-assets is 0%. Total assets: $2M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 50/100 (Partial), Health 50/100 (Partial), Moat 25/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

OSRH SharesGrow Score Overview

30/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 25/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — OSRH

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
OSRH: +0%/yr revenue is, -619.1%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
OSRH: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet OSRH: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 0.1 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
25/100
OSRH: Gross margin is 20.4% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 25/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
OSRH: Net profit margin is -994.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.38-1.79
Volume478.8K
Avg Volume (30D)947.97K
Market Cap$14.03M
Beta (1Y)1.56
Share Statistics
IPO Date2023-03-21
Employees19
CEOKuk Hyoun Hwang
Financial Highlights & Ratios
Revenue (TTM)$2.91M
Gross Profit$592.91K
EBITDA$-18.34M
Net Income$-28.89M
Operating Income$-18.34M
Total Cash$1.7M
Net Debt$-1.7M
Total Assets$1.7M
Price / Sales (P/S)4.83
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS68840D1028

Price Chart

Track all markets on TradingView
OSRH
OSR Holdings, Inc. ↗  ·  NASDAQ Global Market
Healthcare • Biotechnology
0.38 52WK RANGE 1.79

People Also View

EONR
EONR
EON Resources Inc.
$0.70
-0.04%
 JVSA
JVSA
JV SPAC Acquisition Corp. Class A Ordinary Share
$3.64
-65.98%
 SFES
SFES
Safeguard Scientifics, Inc.
$1.65
-0.30%
 BRLI
BRLI
Brilliant Acquisition Corporation
$4.70
-45.85%
 CETU
CETU
Cetus Capital Acquisition Corp.
$2.22
-62.18%
 RFAC
RFAC
RF Acquisition Corp.
$2.70
-68.60%
 BNIX
BNIX
Bannix Acquisition Corp.
$3.01
-66.56%
 ATIF
ATIF
ATIF Holdings Ltd.
$0.64
-12.79%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message